PMID: 7007668Mar 20, 1981Paper

Successful treatment of naturally occurring influenza A/USSR/77 H1N1

JAMA : the Journal of the American Medical Association
L P Van VorisR G Douglas

Abstract

Forty-five university students with proved influenza A/USSR/77 H1N1 infection were randomly treated with either amantadine hydrochloride (14 students), rimantadine hydrochloride (19 students), or placebo (12 students). By 48 hours after initiation of therapy, amantadine and rimantadine recipients had significantly less fever and greater improvement compared with subjects given the placebo. Minor reversible CNS side effects at the end of the five-day course of therapy were observed in one third of the amantadine-treated subjects. However, both amantadine and rimantadine recipients returned to classes earlier and shed smaller amounts of virus than placebo recipients. Thus, both drugs exerted a notable therapeutic effect. Hence, during an influenza outbreak, five days of empirical therapy with amantadine or rimantadine for persons with an influenza-like syndrome should ameliorate clinical symptoms and might decrease spread of virus.

Citations

Sep 1, 1991·Antimicrobial Agents and Chemotherapy·F G HaydenS Pyke
Nov 1, 1990·Antimicrobial Agents and Chemotherapy·R L AtmarR B Couch
Sep 1, 1990·Antimicrobial Agents and Chemotherapy·M T BradyM L Clements
Jun 1, 1989·Antimicrobial Agents and Chemotherapy·A A HolazoR J Wills
Aug 1, 1987·Antimicrobial Agents and Chemotherapy·D S SteinD I Bernstein
Jun 1, 1988·Antimicrobial Agents and Chemotherapy·S ShigetaE De Clercq
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·S D Sears, M L Clements
Feb 1, 1986·Antimicrobial Agents and Chemotherapy·F G Hayden, A S Monto
Jan 10, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·F G Hayden
Oct 3, 2003·Journal of General Internal Medicine·Michael B RothbergDavid N Rose
Apr 29, 2008·Emerging Infectious Diseases·Philip BlumenshineJames Marks
Dec 30, 1999·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·L KaiserF G Hayden
Nov 9, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·S M L WaughW F Carman
Feb 11, 2000·Antiviral Research·J Treanor, A Falsey
Dec 1, 1985·Antiviral Research·D S Freestone
Mar 1, 1994·International Journal of Antimicrobial Agents·J J Treanor
Jul 18, 2002·Seminars in Pediatric Infectious Diseases·Charles G Prober
Aug 1, 1997·Expert Opinion on Investigational Drugs·N J Snell
Dec 19, 2009·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Hanneke van SoestGreet J Boland
Mar 11, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Fred Y Aoki, Guy Boivin
May 4, 2011·Journal of Veterinary Pharmacology and Therapeutics·K T SiaoJ E Ilkiw
Feb 18, 2011·Journal of Veterinary Pharmacology and Therapeutics·K T SiaoJ E Ilkiw
Jan 11, 2005·The American Journal of Medicine·Michael B Rothberg, David N Rose
Jun 1, 1992·Journal of the American Geriatrics Society·F B ColesD L Morse
Jan 21, 2017·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yumi TsuruokaTetsuya Shindo
Apr 21, 2006·The Cochrane Database of Systematic Reviews·T JeffersonD Rivetti
May 1, 1991·Journal of Medical Virology·R D CloverA Davis
Aug 25, 2001·Indian Journal of Pediatrics·B I Asmar, N M Abdel-Haq
Jan 1, 1988·Journal of General Internal Medicine·S WeingartenR D Meyer
Jan 1, 1986·European Journal of Clinical Pharmacology·M C Nahata, M T Brady
Jun 1, 1992·Epidemiology and Infection·J S Nguyen-van-Tam, K G Nicholson
Jun 21, 2019·Vaccines·Erasmus KoteyMunir Iqbal
Nov 22, 2014·The Cochrane Database of Systematic Reviews·Márcia G Alves GalvãoAntonio J L Alves da Cunha
Apr 19, 2005·Expert Opinion on Investigational Drugs·Jonathan A McCullers
Dec 21, 1989·The New England Journal of Medicine·F G HaydenW Soo
Feb 15, 1990·The New England Journal of Medicine·R G Douglas
Jan 1, 1995·Journal of the American Geriatrics Society·I H GomolinF T Sherman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.